(1R,4S,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-N-octylcyclohex-2-enaminium chloride

ID: ALA1922579

PubChem CID: 11359212

Max Phase: Preclinical

Molecular Formula: C15H30ClNO4

Molecular Weight: 287.40

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCN[C@@H]1C=C(CO)[C@H](O)[C@H](O)[C@H]1O.Cl

Standard InChI:  InChI=1S/C15H29NO4.ClH/c1-2-3-4-5-6-7-8-16-12-9-11(10-17)13(18)15(20)14(12)19;/h9,12-20H,2-8,10H2,1H3;1H/t12-,13+,14+,15+;/m1./s1

Standard InChI Key:  MPYFYLDLOZTRGL-SJFOYXCYSA-N

Molfile:  

     RDKit          2D

 21 20  0  0  0  0  0  0  0  0999 V2000
   -1.2208    0.3750    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -3.5792    0.4292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5792   -0.3958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8671   -0.8042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1551   -0.3958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1551    0.4292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8671    0.8458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8671    1.6708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1527    2.0833    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2948    0.8396    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2930   -0.8094    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8671   -1.6292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4413   -0.8094    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7262   -0.3979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0123   -0.8114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7028   -0.4000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4166   -0.8135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1317   -0.4021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8456   -0.8156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5606   -0.4041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2745   -0.8177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  3 11  1  1
  3  4  1  0
  4 12  1  6
  4  5  1  0
  5 13  1  1
  5  6  1  0
 13 14  1  0
  6  7  2  0
 14 15  1  0
 15 16  1  0
  7  8  1  0
 16 17  1  0
 17 18  1  0
  8  9  1  0
 18 19  1  0
  2  3  1  0
 19 20  1  0
  2 10  1  1
 20 21  1  0
  2  7  1  0
M  END

Associated Targets(Human)

GLB1 Tchem Beta-galactosidase (339 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GBA1 Tclin Beta-glucocerebrosidase (14647 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

GLB1 Beta-galactosidase (500 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Beta-galactosidase (59 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Alpha-galactosidase (362 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 287.40Molecular Weight (Monoisotopic): 287.2097AlogP: 0.32#Rotatable Bonds: 9
Polar Surface Area: 92.95Molecular Species: NEUTRALHBA: 5HBD: 5
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 12.83CX Basic pKa: 8.47CX LogP: 0.40CX LogD: -0.70
Aromatic Rings: Heavy Atoms: 20QED Weighted: 0.31Np Likeness Score: 1.50

References

1. Kuno S, Takahashi A, Ogawa S..  (2011)  Transformation of quercitols into 4-methylenecyclohex-5-ene-1,2,3-triol derivatives, precursors for the chemical chaperones N-octyl-4-epi-β-valienamine (NOEV) and N-octyl-β-valienamine (NOV).,  21  (23): [PMID:22001090] [10.1016/j.bmcl.2011.09.067]
2. Kuno S, Higaki K, Takahashi A, Nanba E, Ogawa S.  (2015)  Potent chemical chaperone compounds for GM1-gangliosidosis: N-substituted (+)-conduramine F-4 derivatives,  (2): [10.1039/C4MD00270A]

Source